Photo taken from NCI Division of Cancer Prevention/LinkedIn
Oct 10, 2024, 18:51
Applications are open for the PREVENT Cancer Preclinical Drug Development Program – NCI Division of Cancer Prevention
NCI Division of Cancer Prevention posted the following on LinkedIn:
“The National Cancer Institute (NCI) PREVENT Cancer Preclinical Drug Development Program (PREVENT) is accepting applications to support the preclinical development of innovative interventions and predictive biomarkers for cancer prevention and interception towards clinical applications in high-risk populations. Interested researchers from academia, industry, nonprofits, and government with innovative ideas in precision cancer prevention are encouraged to apply.
Deadline: Monday, November 4, 2024.
academia
Application Deadline
cancer
Cancer Prevention
clinical applications
government
high-risk populations
industry
National Cancer Institute
NCI Division of Cancer Prevention
nonprofits
OncoDaily
Oncology
precision cancer prevention
predictive biomarkers
PREVENT Cancer Preclinical Drug Development Program
researchers
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46